Good Pharma : The Public-Health Model of the Mario Negri Institute

Drawing On Key Concepts In Sociology And Management, This History Describes A Remarkable Institute That Has Elevated Medical Research And Worked Out Solutions To The Troubling Practices Of Commercial Pharmaceutical Research. Good Pharma Is The Answer To Goldacre's bad Pharma, Ethical Research Without Commercial Distortions That Mislead Doctors And Patients. This Extended Case History Of The Mario Negri Institute Describes How A Brilliant Young Researcher, Silvio Garattini, And A Boldly Imaginative Philanthropist, Mario Negri, Conceived Of An Independent, Ethics-based Research Institute To Develop Better Medicines For Patients. It May Sounds Obvious; Yet Patent-based Research Usually Develops Minor Variations. This Book Describe The Institute's Influence On Founding The Who Essential Medicines List, Nurturing The Cochrane Collaboration, And Reforming European Regulations To Reduce Commercial Influences And Increase Transparency. The Mario Negri Model For Pharmacological Research And Policy Offers An Alternative To Today's Costly, Wasteful Drug Development With Few Benefits For Patients. A Revolution Is Needed. . Origins And An American Vision For An Ethical, Independent Research Institute -- The Formative Years : Leadership, Culture And Organization -- Expansions To New Campuses And Integrated Research -- Educating The Public And Future Researchers -- From Measuring Environmental Toxins To Drugs As Contaminants -- Pioneering Ethical Trials For Integrated Research -- Science-based Initiatives Against Dangerous Or Useless Drugs -- International Campaigns Against Harmful Regulations And Practices -- Good Science For Good Pharma : A Public-health Model. Donald W. Light And Antonio F. Maturo. Includes Bibliographical References And Index. Front Matter....Pages i-xviii Introduction....Pages 1-16 Front Matter....Pages 17-17 Origins and an American Vision for an Ethical, Independent Research Institute....Pages 19-33 The Formative Years—Leadership, Culture, and Organization....Pages 35-60 Expansions to New Campuses and Integrated Research....Pages 61-89 Educating the Public and Future Researchers....Pages 91-116 Front Matter....Pages 117-117 From Measuring Environmental Toxins to Drugs as Contaminants....Pages 119-131 Pioneering Ethical Trials for Integrated Research....Pages 133-157 Front Matter....Pages 159-159 Science-Based Initiatives against Dangerous or Useless Drugs....Pages 161-178 International Campaigns against Harmful Regulations and Practices....Pages 179-196 Good Science for Good Pharma—A Public-Health Model....Pages 197-217 Back Matter....Pages 219-280